Feb 2nd Update: This article and video have become the most popular post of all time on this Substack in less than a week!
Etienne Note: This was the most
Dear Subscribers, Good news! We just went over 1,000 subscribers on the Daily News. We are north of 7,000 Subscribers to Five Meme Friday on both our e-mail
by Brian Wang
New South Wales, Australia, reached a record high and more efficient critical milestone temperature of 803 °C for concentrated solar thermal energy storage.
Concentrated Solar Thermal (CST)
by Matt Taibbi
The fix is in. To “protect democracy,” democracy is already being canceled. We just haven’t admitted the implications of this to ourselves yet.
On Sunday, January
by Reinette Senum
In a staggering revelation, investigative journalists uncovered the hidden players, support, organization, and funding to assist mass migration into the United States' southern border. In 2023,
Dear Subscribers, Good news! We just went over 1,000 subscribers on the Daily News. We are north of 7,000 Subscribers to Five Meme Friday on both our e-mail
by CWR
The fine print in health insurance policies is rarely the stuff of casual reading, but 2024 has brought about some unexpected changes that demand our attention. As someone
This is the boilerplate for Govt, Media and Academia Articles: Etienne Note: This article also appears in “Government”, Media and Academia Criminality Exposed, A digest of HUNDREDS and HUNDREDS of
by Michel Chossudovsky
Introduction
WHO Director General Tedros Adhanom Ghebreyesus continues to mislead public opinion worldwide.
There is no such thing as “Disease X”. It’s a hypothetical construct by
by Sasha Latypova
The history of intelligence agencies in the United States, when examined critically, reveals a complex network of organizations operating within the shadows of the government power. The
This is the boilerplate for Govt, Media and Academia Articles: Etienne Note: This article also appears in “Government”, Media and Academia Criminality Exposed, A digest of HUNDREDS and HUNDREDS of
by dw.com
A subsidiary of German pharmaceutical giant Bayer was ordered to pay $2.25 billion (€2.07 billion) to a Pennsylvania man who said he developed cancer from
